Author: Ming Zhong; Aijun Sun; Ting Xiao; Ge Yao; Ling Sang; Xia Zheng; Jinyan Zhang; Xuejuan Jin; Lei Xu; Wenlong Yang; Peng Wang; Kai Hu; Dingyu Zhang; Junbo Ge
Title: A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of a-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19) Document date: 2020_4_21
ID: mvsnybbo_26
Snippet: From day 0 to day 7, the average SOFA Score in the placebo group increased by 1.7 points from 4.3 to 6.0. In the same time period, the average SOFA Score in the ALA treatment group increased by 0.2 points from 3.8 to 4.0 ( Figure 2 ). There was no significant difference in SOFA Score between the placebo group and the ALA group (p=0.36)......
Document: From day 0 to day 7, the average SOFA Score in the placebo group increased by 1.7 points from 4.3 to 6.0. In the same time period, the average SOFA Score in the ALA treatment group increased by 0.2 points from 3.8 to 4.0 ( Figure 2 ). There was no significant difference in SOFA Score between the placebo group and the ALA group (p=0.36).
Search related documents:
Co phrase search for related documents- ALA group and significant difference: 1
- ALA group and treatment group: 1
- ALA group placebo group and placebo group: 1, 2, 3
- ALA treatment group and treatment group: 1
- placebo group and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- placebo group and time period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- placebo group and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- point increase and significant difference: 1, 2, 3, 4
- point increase and time period: 1, 2, 3, 4, 5
- point increase and treatment group: 1
- significant difference and SOFA Score significant difference: 1, 2
- significant difference and time period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- significant difference and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date